From major journals, first or last author from the Institute for Cancer Research
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L(2024) The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy Br J Cancer(in press) DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Møller P, Seppälä TT, Dominguez-Valentin M, Sampson J(2024) Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank J Med Genet(in press) DOI 10.1136/jmg-2024-110385, PubMed 39375027
Ianevski A, Nader K, Driva K, Senkowski W, Bulanova D, Moyano-Galceran L, Ruokoranta T, Kuusanmäki H, Ikonen N, Sergeev P, Vähä-Koskela M, Giri AK, Vähärautio A, Kontro M, Porkka K, Pitkänen E, Heckman CA, Wennerberg K, Aittokallio T(2024) Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones Nat Commun, 15(1), 8579 DOI 10.1038/s41467-024-52980-5, PubMed 39362905
Strunz B, Momayyezi P, Bilev E, Muvva JR, Chen P, Bister J, Schaffer M, Akber M, Cornillet M, Karolinska KI/K COVID-19 Study Group, Horowitz A, Malmberg KJ, Rooyackers O, Aleman S, Ljunggren HG, Björkström NK, Strålin K, Hammer Q(2024) The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19 Genes Immun(in press) DOI 10.1038/s41435-024-00302-6, PubMed 39487235
Palacios D, Majhi RK, Szabo EK, Clement D, Lachota M, Netskar H, Penna L, Krokeide SZ, Vincenti M, Kveberg L, Malmberg KJ(2024) The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration J Immunol, 213(9), 1349-1357 DOI 10.4049/jimmunol.2400228, PubMed 39320215
Ivarsdottir EV, Gudmundsson J, Tragante V, Sveinbjornsson G, Kristmundsdottir S, Stacey SN, Halldorsson GH, Magnusson MI, Oddsson A, Walters GB, Sigurdsson A, Saevarsdottir S, Beyter D, Thorleifsson G, Halldorsson BV, Melsted P, Stefansson H, Jonsdottir I, Sørensen E, Pedersen OB, Erikstrup C, Bøgsted M, Pøhl M, Røder A, Stroomberg HVet al.(2024) Gene-based burden tests of rare germline variants identify six cancer susceptibility genes Nat Genet(in press) DOI 10.1038/s41588-024-01966-6, PubMed 39472694